Organization Profile

You just read:

Health Canada Initiates Review of PTC Therapeutics' New Drug Submission For Translarna™ for the Treatment of Duchenne Muscular Dystrophy

News provided by

PTC Therapeutics

Sep 18, 2015, 08:00 ET